Amdahl, J <br/><br/>
Cost-effectiveness of pazopanib compared with sunitinib in metastatic renal cell carcinoma in Canada.  [electronic resource] 

 -  Current oncology (Toronto, Ont.)  Aug 2016 
 - e340-54 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1198-0052 
<br/><br/><label>Standard No.: </label>10.3747/co.23.2244  doi